| Document |
Document Title |
|
WO/2013/068405 |
The invention relates to a composition that can be used in particular in the photodynamic diagnosis and/or treatment of tumors. The invention further relates to the use of albumins to stabilize chlorin e6 or pharmaceutically acceptable d...
|
|
WO/2013/053927 |
This invention relates to the diagnosis of abnormalities of the epithelial-lined surface of the esophagus and, in particular, to the use of esters of 5-aminolevulinic acid (5-ALA) in methods of photodynamic diagnosis (PDD) of Barrett's e...
|
|
WO/2013/053904 |
This invention relates to the treatment and diagnosis of abnormalities of the epithelial-lined surface of the esophagus and, in particular, to esophageal stents having a surface coating comprising a photosensitizing agent or a precursor ...
|
|
WO/2013/054138 |
A heat patch comprising iron, carbon, potassium chloride and water as active ingredients, has at least two of a heat storage agent, a humectant, and a plasticiser are dissolved in or compatible with the water, thereby allowing the patch ...
|
|
WO/2013/054126 |
The invention provides a method of determining the temperature of a luminescent nanoparticle comprising causing the nanoparticle to luminesce and measuring the luminescence lifetime of luminescent moieties of the nanoparticle, wherein th...
|
|
WO/2013/053099 |
Provided is a hemostatic use of a microbubble combined with ultrasonic cavitation which is mainly used for hemostasis after bleeding following abdominal solid organ injury. Driven by a characteristic pulsed ultrasound, a microbubble ultr...
|
|
WO/2013/050870 |
Device for the activation of water and aqueous solutions, or non-aqueous liquids, through the application of a field of quasi-particles, characterized in that the water - or the solution itself - is exposed to a intense electric field wi...
|
|
WO/2013/051732 |
The objective of the present invention is to provide a drug delivery system which is capable of sustainedly releasing a drug non-invasively at an arbitrary point of time. The present invention relates to a liposome composite body which c...
|
|
WO/2013/050903 |
Ultrasound mediated delivery (USMD), real-time quantitative feedback derived (S264) therefrom, and proceeding by the system based on the feedback all are, in some embodiments, operable automatically and without need for user intervention...
|
|
WO/2013/046076 |
Bubble presence within a region is monitored to determine if a predetermined condition is met such as whether the presence is of sufficient magnitude, the bubbles being subject to energizing (240). In some embodiments, the energizing onl...
|
|
WO/2013/049600 |
In one aspect, composite compositions are described herein. In some embodiments, a composite composition comprises an embolic agent and a plurality of nanoparticles dispersed in the embolic agent, wherein a portion of the nanoparticles a...
|
|
WO/2013/041500 |
The present invention relates to a microbubble complex comprising a microbubble having an outer shell comprising a mixture of native and denatured albumin encapsulating a perfiuorocarbon gas, a therapeutic agent, a bifunctional linker ha...
|
|
WO/2013/041744 |
The invention relates to a method for applying a device generating a laser beam in order to induce photopolymerisation and photocatalysis in products with active principles for the hair, such as products used for beautifying and restruct...
|
|
WO/2013/040688 |
The present document describes a method of increasing expression of a recombinant protein of an isolated eukaryotic cell comprising a recombinant DNA, by exposing the isolated eukaryotic cell to ultrasound having a frequency from greater...
|
|
WO/2013/035750 |
The present invention provides a fluorescent molecule probe for efficient fluorescent detection (visualization) of tumors or for implementing fluorescent detection and photodynamic therapy; more specifically, the present invention provid...
|
|
WO/2013/035739 |
Provided are a thermotherapy material, a thermotherapy system and a thermotherapy method capable of accurately controlling the amount of heat generated by irradiation with a laser. This thermotherapy material has as the main component se...
|
|
WO/2013/026429 |
The invention relates to a novel use of a YT cell line that is suitable for treating malignant diseases, in particular multiple myeloma and malignant lymphoma as well as viral infections, including hepatitis, in particular hepatitis C, a...
|
|
WO/2013/029025 |
The present invention provides methods and compositions for the remote control of cell function based on the use of radiofrequency waves to excite nanoparticles targeted to specific cell types. The nanoparticles may be applied to the tar...
|
|
WO/2013/020204 |
Biodegradable polymeric nanoparticles comprising an inner core formed of a photodynamic agent capable of being activated to generate cytotoxic singlet oxygen are prepared. These nanoparticles have anti-cell proliferation activity and are...
|
|
WO/2013/019137 |
The present invention relates to methods for producing oxide ferrimagnetics with spinel structure and iron oxide nanoparticles by mechanochemical synthesis, oxide ferrimagnetics with spinel structure and iron oxide nanoparticles of ultra...
|
|
WO/2013/014997 |
A novel metal salen complex compound having auto-magnetic properties, and a derivative thereof are provided. The present invention is a metal salen complex compound comprising any of the listed compounds.
|
|
WO/2013/009475 |
The present disclosure relates to compositions and methods of killing cells. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody- IR700 molecu...
|
|
WO/2013/007584 |
The invention relates to a method for sterilising functionalised coated surfaces containing nucleotides and/or nucleotide derivatives, according to which a) the surface is coated in a functionalising manner with nucleotides and/or nucleo...
|
|
WO/2013/009475 |
The present disclosure relates to compositions and methods of killing cells. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody- IR700 molecu...
|
|
WO/2013/009688 |
A system and method for light stimulation within a medium. The system has a reduced-voltage x-ray source configured to generate x-rays from a peak applied cathode voltage at or below 105 kVp, and a plurality of energy-emitting particles ...
|
|
WO/2013/007584 |
The invention relates to a method for sterilising functionalised coated surfaces containing nucleotides and/or nucleotide derivatives, according to which a) the surface is coated in a functionalising manner with nucleotides and/or nucleo...
|
|
WO/2013/005379 |
The purpose of the present invention is to provide photodynamic therapy (PDT) and photodynamic diagnosis (PDD) suitable for diagnosis and therapy of sites requiring a certain degree of invasion depth, such as subcutaneous cancers and lym...
|
|
WO/2013/006176 |
A method of administering photodynamic therapy includes using a microwave frequency-sensitive light-emitting polymer as a light source to excite a administered photosensitizer to exert cytotoxicity in situ at a site containing undesired ...
|
|
WO/2013/001451 |
A vector for the spatially and temporally controlled release of an active agent comprising nanoparticles of gold coated with a surfactant and an active agent bound to the said surfactant by means of a photocleavable bond, the said vector...
|
|
WO/2012/175730 |
The invention relates to 10H-benzo[g]pteridine-2,4-dione derivatives, to the production thereof, and to the use thereof.
|
|
WO/2012/175729 |
The invention relates to 10H-benzo[g]pteridine-2,4-dione derivatives, to the production thereof, and to the use thereof.
|
|
WO/2012/175706 |
The invention relates to the use of 10H-benzo[g]pteridine-2,4-dione derivatives as photosensitizers in the inactivation of microorganisms.
|
|
WO/2012/175379 |
The invention relates to a homeopathic composition for effectively treating and preventing back, sciatic, or lumbar pain. The composition includes Cuprum metallicum, Staphysagria, Ribes nigrum, and preferably includes Spigelia.
|
|
WO/2012/174394 |
The disclosure provides methods of treating cancer, tumors, and neoplasias by administering ionizing radiation and an anti-DLL4 antibody or a DLL4-binding fragment.
|
|
WO/2012/172821 |
Provided is a therapeutic agent capable of treating allergic rhinitis in a safe, simple, and noninvasive manner substantially without side effects and physical pain to a patient. Provided is a therapeutic agent for allergic rhinitis for ...
|
|
WO/2012/167230 |
The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.
|
|
WO/2012/160450 |
The invention relates to a modular transport platform (MTP) for delivering active, diagnostic or research substances to predesigned intracellular compartments of target cells. The MTP includes functional modules within one molecule to ac...
|
|
WO/2012/160549 |
Provided are homeopathic combinations, carriers imprinted with the bioresonance of said combinations and articles of manufacture comprising the same.
|
|
WO/2012/153493 |
Provided are a therapy and/or a diagnostic agent capable of being used for photodynamic therapy (PDT) or photodynamic diagnosis (PDD) capable of using infrared-spectrum light such as near-infrared light (NIR), infrared light, and far inf...
|
|
WO/2012/143739 |
The invention provides microbubble-sonosensitiser complexes in which sonosensitisers are attached or otherwise associated with a microbubble. Such complexes find use in methods of sonodynamic therapy where the complex permits effective d...
|
|
WO/2012/130336 |
The invention relates generally to intradermal, transdermal, and/or transmembrane delivery of biologically active substances in the epidermis and/or through the skin, sub-dermal tissues, blood vessels and cellular membranes without causi...
|
|
WO/2012/132141 |
Provided are: a composition for delivering a drug into a cell, said composition comprising gas-persaturated water; and a method for delivering a drug into a cell, said method comprising dissolving the drug in gas-persaturated water and t...
|
|
WO/2012/128326 |
[Problem] To provide nanoparticles for photo dynamic therapy, the nanoparticles being capable of building a system which can accurately determine sites of malignant tumors and the like, especially, metastatic spinal tumors that should be...
|
|
WO/2012/125693 |
The present invention provides nanoparticles including a metallic core having a length along each axis of from 1 to 100 nanometers and a coating disposed on at least part of the surface of the metallic core, wherein the coating comprises...
|
|
WO/2012/125693 |
The present invention provides nanoparticles including a metallic core having a length along each axis of from 1 to 100 nanometers and a coating disposed on at least part of the surface of the metallic core, wherein the coating comprises...
|
|
WO/2012/119775 |
The invention relates to a computer-aided simulation tool, in particular to computer-aided simulation methods, for providing assistance in the planning of thermotherapy, and to suitably configured computer equipment. The thermotherapy co...
|
|
WO/2012/113658 |
The invention relates to a medical appliance for heating human or animal tissue. The appliance comprises a first magnetic field device (1, 2) for generating a first magnetic field (M1) in the tissue to be heated, wherein the first magnet...
|
|
WO/2012/115659 |
Disclosed are methods, compositions and kits pertaining to controlled delivery of compounds. In certain aspects and embodiments the present technology relates to compositions and methods for controlled delivery of a compound such as a bi...
|
|
WO/2012/113860 |
The invention relates to a compound of formula (1): where R1 through R8, which can be identical or different from each other, each are selected from of the group comprising hydrogen and the radical -(CH2)k-X, where k is a whole number fr...
|
|
WO/2012/112547 |
Core-excited nanoparticle thermotherapy (CENT) represents a new paradigm in thermotherapy. The CENT method employs core-shell nanoparticles. The core of the nanoparticles is formed from one or more core-exciting, energy absorbing materia...
|
